Department of Ophthalmology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Invest Ophthalmol Vis Sci. 2013 Jul 22;54(7):4892-9. doi: 10.1167/iovs.13-11872.
To evaluate the expression of ATP-sensitive potassium (K(ATP)) channel subunits and study the effect of K(ATP) channel openers diazoxide and nicorandil on intraocular pressure (IOP) in an in vivo mouse model.
Expression of K(ATP) channel subunits in normal C57BL/6 mouse eyes was studied by immunohistochemistry and confocal microscopy. Wild-type C57BL/6 mice were treated with K(ATP) channel openers diazoxide (n = 10) and nicorandil (n = 10) for 14 days. Similar treatments with diazoxide were performed on K(ir)6.2((-/-)) mice (n = 10). IOP was recorded with a handheld tonometer 1 hour, 4 hours, and 23 hours following daily treatment. Posttreatment histology was examined by light and transmission electron microscopy.
The K(ATP) channel subunits SUR2B, K(ir)6.1, and K(ir)6.2 were identified in all tissues within mouse eyes. Treatment with diazoxide in wild-type mice decreased IOP by 21.5 ± 3.2% with an absolute IOP reduction of 3.9 ± 0.6 mm Hg (P = 0.002). Nicorandil also decreased IOP (18.9 ± 1.8%) with an absolute IOP reduction of 3.4 ± 0.4 mm Hg (P = 0.002). Treatment with diazoxide in K(ir)6.2((-/-)) mice had no effect on IOP. No morphological abnormalities were observed in diazoxide- or nicorandil-treated eyes.
K(ATP) channel openers diazoxide and nicorandil are effective regulators of IOP in mouse eyes. K(ir)6.2 appears to be a major K(ATP) channel subunit through which IOP is lowered following treatment with diazoxide.
评估三磷酸腺苷敏感性钾(K(ATP))通道亚单位的表达,并研究 K(ATP)通道开放剂二氮嗪和尼克地尔对活体小鼠模型眼内压(IOP)的影响。
通过免疫组织化学和共聚焦显微镜研究正常 C57BL/6 小鼠眼中 K(ATP)通道亚单位的表达。用 K(ATP)通道开放剂二氮嗪(n = 10)和尼克地尔(n = 10)治疗野生型 C57BL/6 小鼠 14 天。在 K(ir)6.2((-/-))小鼠(n = 10)上进行类似的二氮嗪处理。每日治疗后 1 小时、4 小时和 23 小时用手持眼压计记录 IOP。用光镜和透射电镜检查治疗后的组织学。
在小鼠眼内所有组织中均鉴定出 K(ATP)通道亚单位 SUR2B、K(ir)6.1 和 K(ir)6.2。在野生型小鼠中,二氮嗪治疗使 IOP 降低 21.5 ± 3.2%,绝对 IOP 降低 3.9 ± 0.6 mmHg(P = 0.002)。尼克地尔也降低了 IOP(18.9 ± 1.8%),绝对 IOP 降低 3.4 ± 0.4 mmHg(P = 0.002)。在 K(ir)6.2((-/-))小鼠中,二氮嗪治疗对 IOP 没有影响。在二氮嗪或尼克地尔治疗的眼中未观察到形态异常。
K(ATP)通道开放剂二氮嗪和尼克地尔是小鼠眼内压的有效调节剂。K(ir)6.2 似乎是通过二氮嗪治疗降低 IOP 的主要 K(ATP)通道亚单位。